Inflammatory and immune cells in tumour angiogenesis and arteriogenesis

Breast Cancer Research

Volumn 5, Issue 2, 2003, Pages 83-88

  Yu, Joanne L ^a   Rak, Janusz W ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Angiogenesis; Arteriogenesis; Cancer; Immunity; Inflammation

Indexed keywords

GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE; COLONY STIMULATING FACTOR 1; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CAPILLARY; CELL INFILTRATION; CELL KINETICS; DISEASE ASSOCIATION; DRUG DESIGN; ENDOTHELIUM CELL; HOST; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; ISCHEMIA; MACROPHAGE; MICROENVIRONMENT; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN SECRETION; REVIEW; STROMA CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; BLOOD VESSEL; BREAST TUMOR; METABOLISM; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; BREAST NEOPLASMS; CHEMOKINE CCL2; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037686184     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr573     Document Type: Review

References (87)

1. Dvorak HF: Tumors: wounds that do not heal. N Engl J Med 1986, 315:1650-1659.
2. + macrophages in antitumor cytotoxicity. Lab Invest 1992, 67:166-174.
3. Rosenberg SA: Progress in human tumour immunology and immunotherapy. Nature 2001, 411:380-384.
4. Carr I: The Macrophage and Cancer. Edinburgh: Econoprint; 1977.
5. Urban JL, Shepard HM, Rothstein JL, Sugarman BJ, Schreiber H: Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 1986, 83:5233-5237.
6. Pozzi LA, Weiser WY: Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cell Immunol 1992, 145:372-379.
7. Polverini PJ, Cotran RS, Gimbrone MA, Unanue ER: Activated macrophages induce vascular proliferation. Nature 1977, 269:804-806.
8. Sidky YA, Auerbach R: Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs-host reaction. J Exp Med 1975, 141:1084-1100.
9. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999, 13:1382-1397.
10. Bingle L, Brown NJ, Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196:254-265.
11. Crowther M, Brown NJ, Bishop ET, Lewis CE: Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 2001, 70:478-490.
12. Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490.
13. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ: Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 2002, 94:1134-1142.
14. Kalra VK, Shen Y, Sultana C, Rattan V: Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes. Am J Physiol 1996, 271:H2025-H2034.
15. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996, 56:4625-4629.
16. Turner L, Scotton C, Negus R, Balkwill F: Hypoxia inhibits macrophage migration. Eur J Immunol 1999, 29:2280-2287.
17. Leek RD, Landers RJ, Harris AL, Lewis CE: Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999, 79:991-995.
18. Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CE: Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 2000, 192:150-158.
19. Lee AH, Happerfield LC, Bobrow LG, Millis RR: Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol 1997, 50:669-673.
20. Volodko N, Reiner A, Rudas M, Jakesh R: Tumour-associated macrophages in breast cancer and their prognostic correlations. Breast 1998, 7:99-105.
21. Goede V, Brogelli L, Ziche M, Augustin HG: Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 1999, 82:765-770.
22. Tang RP, Kacinski B, Validire P, Beuvon F, Sastre X, Benoit P, dela Rochefordiere A, Mosseri V, Pouillart P, Scholl S: Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells? J Cell Biochemistry 1990, 44:189-198.
23. van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD: RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2000, 2:418-425.
24. Graves DT, Jiang YL, Williamson MJ, Valente AJ: Identification of monocyte chemotactic activity produced by malignant cells. Science 1989, 245:1490-1493.
25. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ: Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989, 169:1449-1459.
26. Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S et al.: The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 1995, 95:2391-2396.
27. Sato K, Kuratsu J, Takeshima H, Yoshimura T, Ushio Y: Expression of monocyte chemoattractant protein-1 in meningioma. J Neurosurg 1995, 82:874-878.
28. Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N: Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 2002, 440:583-588.
29. Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K, Toi M: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 2001, 92:1085-1091.
30. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000, 6:3282-3289.
31. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25.
32. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990, 172:1535-1545.
33. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996, 87:3336-3343.
34. Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T, Shibuya M: Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 2001, 97:785-791.
35. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL: Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000, 190:430-436.
36. Duyndam MC, Hilhorst MC, Schluper HM, Verheul HM, van Diest PJ, Kraal G, Pinedo HM, Boven E: Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts. Am J Pathol 2002, 160:537-548.
37. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, et al.: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 1993, 53:2912-2918.
38. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W: The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996, 271:17629-17634.
39. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M: Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001, 159:893-903.
40. Adini A, Kornaga T, Firoozbakht F, Benjamin LE: Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 2002, 62:2749-2752.
41. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH: CSF-1: a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 1983, 21:151-159.
42. Ramakrishnan S, Xu FJ, Brandt SJ, Niedel JE, Bast RC Jr, Brown EL: Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 1989, 83:921-926.
43. Tang R, Beuvon F, Ojeda M, Mosseri V, Pouillart P, Scholl S: M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem 1992, 50:350-356.
44. Kacinski BM: CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 1995, 27:79-85.
45. Nowicki A, Szenajch J, Ostrowska G, Wojtowicz A, Wojtowicz K, Kruszewski AA, Maruszynski M, Aukerman SL, Wiktor-Jedrzejczak W: Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int J Cancer 1996, 65:112-119.
46. Lin EY, Nguyen AV, Russell RG, Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193:727-740.
47. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J Leukoc Biol 1994, 55:410-422.
48. Sorbo J, Jakobsson A, Norrby K: Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. Int J Exp Pathol 1994, 75:43-50.
49. Pepper MS: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001, 21:1104-1117.
50. Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R: Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002, 295:140-143.
51. Dong Z, Kumar R, Yang X, Fidler IJ: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997, 88:801-810.
52. Patterson BC, Sang QA: Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 1997, 272:28823-28825.
53. Jussila L, Alitalo K: Vascular growth factors and lymphangiogenesis. Physiol Rev 2002, 82:673-700.
54. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002, 161:947-956.
55. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296:1883-1886.
56. Folkman J: Tumor angiogenesis. In Cancer Medicine. Edited by Holland JF, Bast RC, Morton DL, Frei E, Kufe DW, Weichselbaum RR. Baltimore: Williams & Wilkins; 1997:181-204.
57. Scholz D, Cai WJ, Schaper W: Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 2001, 4:247-257.
58. Schaper J, Konig R, Franz D, Schaper W: The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study. Virchows Arch A Pathol Anat Histol 1976, 370:193-205.
59. Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Wiesnet M, Busse R, Schaper J, Schaper W: Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch 2000, 436:257-270.
60. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W: Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998, 101:40-50.
61. Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W: Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 2000, 79:850-857.
62. Xiong M, Elson G, Legarda D, Leibovich SJ: Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 1998, 153:587-598.
63. Madtes DK, Raines EW, Sakariassen KS, Assoian RK, Sporn MB, Bell GI, Ross R: Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell 1988, 53:285-293.
64. Rappolee DA, Mark D, Banda MJ, Werb Z: Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988, 241:708-712.
65. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, StrieterRM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
66. Leek RD, Harris AL, Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 1994, 56:423-435.
67. Nagaoka H, Iino Y, Takei H, Morishita Y: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer. Int J Oncol 1998, 13:449-454.
68. Martinet Y, Bitterman PB, Mornex JF, Grotendorst GR, Martin GR, Crystal RG: Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature 1986, 319:158-160.
69. Ziche M, Morbidelli L, Geppetti P, Maggi CA, Dolara P: Substance P induces migration of capillary endothelial cells: a novel NK-1 selective receptor mediated activity. Life Sci 1991, 48:L7-L11.
70. Humes JL, Bonney RJ, Pelus L, Dahlgren ME, Sadowski SJ, Kuehl FA Jr, Davies P: Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature 1977, 269:149-151.
71. Jaffe EA, Ruggiero JT, Falcone DJ: Monocytes and macrophages synthesize and secrete thrombospondin. Blood 1985, 65:79-84.
72. Fleit HB, Rabinovitch M: Production of interferon by in vitro derived bone marrow macrophages. Cell Immunol 1981, 57:495-504.
73. Robinson BW, McLemore TL, Crystal RG: Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985, 75:1488-1495.
74. Klimetzek V, Sorg C: Lymphokine-induced secretion of plasminogen activator by murine macrophages. Eur J Immunol 1977, 7:185-187.
75. Xu Y, Hagege J, Doublet JD, Callard P, Sraer JD, Ronne E, Rondeau E: Endothelial and macrophage upregulation of urokinase receptor expression in human renal cell carcinoma. Hum Pathol 1997, 28:206-213.
76. Hildenbrand R, Dilger I, Horlin A, Stutte HJ: Urokinase and macrophages in tumour angiogenesis. Br J Cancer 1995, 72:818-823.
77. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Dalli SJ: Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 1998, 188:1135-1145.
78. Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, Lippert U, Henz BM, Moller A: Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998, 9:875-884.
79. Reed JA, Albino AP, McNutt NS: Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995, 72:215-222.
80. Pennington DW, Lopez AR, Thomas PS, Peck C, Gold WM: Dog mastocytoma cells produce transforming growth factor beta 1. J Clin Invest 1992, 90:35-41.
81. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997, 77:1033-1079.
82. Norrby K: Mast cells and angiogenesis. Acta Path Microbiol Scand 2002, 110:355-371.
83. Bashkin P, Razin E, Eldor A, Vlodavsky I: Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood 1990, 75:2204-2212.
84. Cassatella MA: Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999, 73:369-509.
85. Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA: Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999, 162:4928-4937.
86. Borregaard N, Cowland JB: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997, 89:3503-3521.
87. Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D, Presta M, Albini A, Cassatella MA: Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol 2002, 168:5798-5804.